Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a clinical trial registry record describing a Phase 1/2 study that is actively recruiting with no results yet posted; it represents early-stage evaluation of a novel combination therapy.
This is a recruiting observational registry study with no reported results; it measures patient satisfaction and quality of life with a surrogate endpoint (TASQ-SC), not clinical outcomes, and cannot inform practice decisions until data are published.
This is a Phase 2 trial registration with no results reported; it describes a planned study of an investigational drug in combination therapy for extensive-stage SCLC, addressing dose optimization and safety.
This is a Phase 1/2 trial registration with no posted results; it describes a planned early-phase study of a novel combination in a difficult-to-treat cancer.
This is a Phase 2, single-arm feasibility study with no results yet posted; it is designed to evaluate concurrent SBRT and immunotherapy but carries no outcome data to assess efficacy or safety.